SignatureFD’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $184K | Sell |
655
-79
| -11% | -$20.8K | ﹤0.01% | 1148 |
|
|
2026
Q1 | $196K | Buy |
734
+25
| +4% | +$6.77K | ﹤0.01% | 1019 |
|
|
2025
Q4 | $178K | Sell |
709
-46
| -6% | -$12.2K | ﹤0.01% | 1025 |
|
|
2025
Q3 | $217K | Sell |
755
-61
| -7% | -$16.3K | ﹤0.01% | 923 |
|
|
2025
Q2 | $214K | Buy |
816
+171
| +27% | +$41.6K | ﹤0.01% | 886 |
|
|
2025
Q1 | $150K | Buy |
645
+57
| +10% | +$13.8K | ﹤0.01% | 1011 |
|
|
2024
Q4 | $135K | Buy |
588
+52
| +10% | +$11.9K | ﹤0.01% | 1068 |
|
|
2024
Q3 | $120K | Sell |
536
-38
| -7% | -$8.35K | ﹤0.01% | 1134 |
|
|
2024
Q2 | $117K | Sell |
574
-371
| -39% | -$75.5K | ﹤0.01% | 1094 |
|
|
2024
Q1 | $206K | Sell |
945
-296
| -24% | -$65.2K | ﹤0.01% | 821 |
|
|
2023
Q4 | $282K | Buy |
1,241
+265
| +27% | +$55.7K | 0.01% | 667 |
|
|
2023
Q3 | $196K | Sell |
976
-114
| -10% | -$24K | 0.01% | 757 |
|
|
2023
Q2 | $226K | Sell |
1,090
-116
| -10% | -$22.5K | 0.01% | 712 |
|
|
2023
Q1 | $238K | Sell |
1,206
-289
| -19% | -$59.5K | 0.01% | 663 |
|
|
2022
Q4 | $302K | Buy |
1,495
+131
| +10% | +$25.6K | 0.01% | 556 |
|
|
2022
Q3 | $240K | Sell |
1,364
-119
| -8% | -$24.4K | 0.01% | 611 |
|
|
2022
Q2 | $299K | Buy |
1,483
+114
| +8% | +$24.3K | 0.01% | 546 |
|
|
2022
Q1 | $310K | Sell |
1,369
-15
| -1% | -$3.53K | 0.01% | 566 |
|
|
2021
Q4 | $374K | Buy |
1,384
+65
| +5% | +$16.1K | 0.01% | 489 |
|
|
2021
Q3 | $319K | Buy |
1,319
+115
| +10% | +$29K | 0.01% | 515 |
|
|
2021
Q2 | $285K | Buy |
1,204
+14
| +1% | +$3.19K | 0.01% | 528 |
|
|
2021
Q1 | $261K | Buy |
1,190
+238
| +25% | +$47.8K | 0.01% | 495 |
|
|
2020
Q4 | $167K | Buy |
952
+9
| +1% | +$1.55K | 0.01% | 595 |
|
|
2020
Q3 | $152K | Sell |
943
-2
| -0.2% | -$317 | 0.01% | 577 |
|
|
2020
Q2 | $135K | Buy |
945
+51
| +6% | +$7.06K | 0.01% | 580 |
|
|
2020
Q1 | $97K | Buy |
894
+199
| +29% | +$28.7K | 0.01% | 649 |
|
|
2019
Q4 | $101K | Sell |
695
-434
| -38% | -$62.7K | 0.01% | 703 |
|
|
2019
Q3 | $163K | Buy |
1,129
+242
| +27% | +$35.3K | 0.01% | 471 |
|
|
2019
Q2 | $132K | Buy |
887
+367
| +71% | +$51.2K | 0.01% | 527 |
|
|
2019
Q1 | $68K | Buy |
520
+63
| +14% | +$7.76K | 0.01% | 772 |
|
|
2018
Q4 | $50K | Sell |
457
-128
| -22% | -$17.1K | ﹤0.01% | 843 |
|
|
2018
Q3 | $87K | Sell |
585
-7
| -1% | -$1.06K | 0.01% | 689 |
|
|
2018
Q2 | $91K | Sell |
592
-41
| -6% | -$6.19K | 0.01% | 644 |
|
|
2018
Q1 | $88K | Buy |
+633
| New | +$93K | 0.01% | 583 |
|
|
2016
Q4 | – | Sell |
-257
| Closed | -$30K | – | 780 |
|
|
2016
Q3 | $30K | Buy |
257
+98
| +62% | +$11.5K | ﹤0.01% | 684 |
|
|
2016
Q2 | $18K | Buy |
159
+78
| +96% | +$8.39K | ﹤0.01% | 744 |
|
|
2016
Q1 | $8K | Sell |
81
-56
| -41% | -$5.37K | ﹤0.01% | 891 |
|
|
2015
Q4 | $15K | Buy |
137
+66
| +93% | +$6.81K | ﹤0.01% | 641 |
|
|
2015
Q3 | $7K | Buy |
71
+16
| +29% | +$1.66K | ﹤0.01% | 757 |
|
|
2015
Q2 | $6K | Buy |
55
+49
| +817% | +$5.1K | ﹤0.01% | 719 |
|
|
2015
Q1 | $1K | Sell |
6
-58
| -91% | -$5.96K | ﹤0.01% | 889 |
|
|
2014
Q4 | $6K | Hold |
64
| – | – | ﹤0.01% | 579 |
|
|
2014
Q3 | $6K | Sell |
64
-31
| -33% | -$2.8K | ﹤0.01% | 521 |
|
|
2014
Q2 | $8K | Buy |
95
+31
| +48% | +$2.69K | ﹤0.01% | 491 |
|
|
2014
Q1 | $5K | Hold |
64
| – | – | ﹤0.01% | 534 |
|
|
2013
Q4 | $5K | Buy |
+64
| New | +$5.46K | ﹤0.01% | 521 |
|
Other funds holding LH
RRAM
JIC
BCWM
AAM
DIA
SFA
WCM
HPCM
MCM
ET
SignatureFD's LH Position: Q2 2026 in Review
SignatureFD reduced its Labcorp (LH) stake by 11% in Q2 2026, selling an estimated $20.8K and leaving 655 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #1148.
SignatureFD first reported a position in LH in Q4 2013 and has held it in 46 quarters since. The position peaked at $374K in Q4 2021. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- SignatureFD held 655 shares of Labcorp worth $184K as of Q2 2026.
- SignatureFD sold 79 Labcorp shares in Q2 2026, an estimated $20.8K.
- Labcorp made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #1148 holding.
- SignatureFD first reported a position in Labcorp in Q4 2013 and has held it in 46 quarters since.
- SignatureFD's Labcorp position peaked at $374K in Q4 2021.
- 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.